Clinical Trials in Michigan

Showing 3601-3620 of 7,755 trials

Study to Evaluate the Safety and Efficacy of High Dose Intravenous Immune Globulin (IVIG) Plus Standard Medical Treatment (SMT) Versus SMT Alone in Participants in Intensive Care Unit (ICU) With Coronavirus Disease (COVID-19)

NCT04480424

The purpose of the study is to determine if a high dose of Intravenous Immune Globulin (IVIG) plus Standard Medical Treatment (SMT) can reduce all-cause mortality versus SMT alone in hospitalized participants with COVID-19 requiring admission to the ICU through Day 29.

COVID-19

Grifols Therapeutics LLC100 participantsStarted Sep 2020

Chandler, Arizona, United States • Coronado, California, United States • Chicago, Illinois, United States +15 more locations

COMPLETEDPhase 383 miles

(VOYAGER) Study of Avapritinib vs Regorafenib in Patients With Locally Advanced Unresectable or Metastatic GIST

NCT03465722

This is an open-label, randomized, Phase 3 study in patients with locally advanced unresectable or metastatic GIST (advanced GIST) of avapritinib (also known as BLU-285) versus regorafenib in patients previously treated with imatinib and 1 or 2 other TKIs.

GIST

Blueprint Medicines Corporation476 participantsStarted Mar 2018

Phoenix, Arizona, United States • Santa Monica, California, United States • Aurora, Colorado, United States +111 more locations

Study to Evaluate the Safety and Efficacy of High Dose Intravenous Immune Globulin (IVIG) Plus Standard Medical Treatment (SMT) Versus SMT Alone in Participants in Intensive Care Unit (ICU) With Coronavirus Disease (COVID-19)

(VOYAGER) Study of Avapritinib vs Regorafenib in Patients With Locally Advanced Unresectable or Metastatic GIST

Find Trials by Condition in Michigan

A Study of Pembrolizumab (MK-3475) in Combination With Etoposide/Platinum (Cisplatin or Carboplatin) for Participants With Extensive Stage Small Cell Lung Cancer (MK-3475-604/KEYNOTE-604)

A Study Exploring the Safety and Efficacy of INCAGN01949 in Combination With Immune Therapies in Advanced or Metastatic Malignancies

Study of Vadadustat in Hemodialysis Participants With Anemia Switching From Epoetin Alfa

Phase III Study of Lenalidomide and Dexamethasone With or Without Elotuzumab to Treat Newly Diagnosed, Previously Untreated Multiple Myeloma

Chronic Total Occlusion Percutaneous Coronary Intervention Study

Safety and Efficacy of Nerinetide (NA-1) in Subjects Undergoing Endovascular Thrombectomy for Stroke

The Impact of "First-Line" Rhythm Therapy on AF Progression

Real-World Experience Study of Elagolix For the Treatment of Endometriosis in Canada

Fibromyalgia Outcome Research Trial Evaluating Synergistic Suppression of HSV-1

Trial of Roflumilast in Asthma Management (TRIM)

Dysport® Adult Upper Limb Spasticity Extension Study

Study of Dalantercept and Sorafenib in Patients With Advanced Hepatocellular Carcinoma

A Study of Epacadostat in Combination With Pembrolizumab and Chemotherapy in Participants With Advanced or Metastatic Solid Tumors (ECHO-207/KEYNOTE-723)

Open Label Extension to Assess the Safety of Long-Term Treatment With Ampion for Severe Osteoarthritis (OA) of the Knee

A Study of ALRN-6924 for the Prevention of Chemotherapy-induced Side Effects (Chemoprotection)

Effects of Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibition on Arterial Wall Inflammation in Patients With Elevated Lipoprotein(a) (Lp(a))

Dysport® Adult Lower Limb Spasticity Study

Long-Term Retention of Gadolinium in Bone